Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Histone Deacetylase (HDAC) Inhibition Induces IκB Kinase (IKK)-dependent Interleukin-8/CXCL8 Expression in Ovarian Cancer Cells
Himavanth R. Gatla, Yue Zou, Mohammad M. Uddin, et al.
Journal of Biological Chemistry (2017) Vol. 292, Iss. 12, pp. 5043-5054
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Flavonoids and Other Polyphenols Act as Epigenetic Modifiers in Breast Cancer
Priyanga Selvakumar, Aja Badgeley, Paige Murphy, et al.
Nutrients (2020) Vol. 12, Iss. 3, pp. 761-761
Open Access | Times Cited: 161
Wnt/β-Catenin Signaling: The Culprit in Pancreatic Carcinogenesis and Therapeutic Resistance
Monish Ram Makena, Himavanth R. Gatla, Dattesh Verlekar, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 17, pp. 4242-4242
Open Access | Times Cited: 136
Immunoepigenetics Combination Therapies: An Overview of the Role of HDACs in Cancer Immunotherapy
Debarati Banik, Sara Moufarrij, Alejandro Villagra
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 9, pp. 2241-2241
Open Access | Times Cited: 109
Regulation of Chemokines and Cytokines by Histone Deacetylases and an Update on Histone Decetylase Inhibitors in Human Diseases
Himavanth R. Gatla, Nethaji Muniraj, Prashanth Thevkar, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 5, pp. 1110-1110
Open Access | Times Cited: 83
Ovarian cancer: epigenetics, drug resistance, and progression
Weiwei Xie, Huizhen Sun, Xiaoduan Li, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 66
cGAS/STING signaling pathway in gynecological malignancies: From molecular mechanisms to therapeutic values
Danyang Zhang, Bingxue Zhang
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Diverse Epigenetic Regulations of Macrophages in Atherosclerosis
Hongmei Yang, Yue Sun, Qingchao Li, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 31
miRNA-34a decreases ovarian cancer cell proliferation and chemoresistance by targeting HDAC1
Teng Lv, Kejuan Song, Lili Zhang, et al.
Biochemistry and Cell Biology (2018) Vol. 96, Iss. 5, pp. 663-671
Closed Access | Times Cited: 55
Combination Therapies Targeting HDAC and IKK in Solid Tumors
Ivana Vancurova, Mohammad M. Uddin, Yue Zou, et al.
Trends in Pharmacological Sciences (2017) Vol. 39, Iss. 3, pp. 295-306
Open Access | Times Cited: 51
HDAC inhibitors promote intestinal epithelial regeneration via autocrine TGFβ1 signalling in inflammation
Marie Friedrich, Lorenz Gerbeth, Marco Gerling, et al.
Mucosal Immunology (2019) Vol. 12, Iss. 3, pp. 656-667
Open Access | Times Cited: 50
The proto-oncogene Bcl3 induces immune checkpoint PD-L1 expression, mediating proliferation of ovarian cancer cells
Yue Zou, Mohammad M. Uddin, Sveta Padmanabhan, et al.
Journal of Biological Chemistry (2018) Vol. 293, Iss. 40, pp. 15483-15496
Open Access | Times Cited: 48
Targeting IκappaB kinases for cancer therapy
Nikee Awasthee, Vipin Rai, Srinivas Chava, et al.
Seminars in Cancer Biology (2018) Vol. 56, pp. 12-24
Open Access | Times Cited: 44
An updated review on the role of the CXCL8-CXCR1/2 axis in the progression and metastasis of breast cancer
Amaresh Mishra, Kamrul Hassan Suman, Nisha Nair, et al.
Molecular Biology Reports (2021) Vol. 48, Iss. 9, pp. 6551-6561
Closed Access | Times Cited: 31
Discovery of HDAC6-Selective Inhibitor NN-390 with in Vitro Efficacy in Group 3 Medulloblastoma
Nabanita Nawar, Shazreh Bukhari, Ashley Adile, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 4, pp. 3193-3217
Closed Access | Times Cited: 21
Functions of the CXC ligand family in the pancreatic tumor microenvironment
N. Lee, Mehrdad Nikfarjam, Hong He
Pancreatology (2018) Vol. 18, Iss. 7, pp. 705-716
Closed Access | Times Cited: 36
Effects of ginsenoside Rg3 on epigenetic modification in ovarian cancer cells
Lingqin Zhao, Huafeng Shou, Lü Chen, et al.
Oncology Reports (2019)
Open Access | Times Cited: 35
Thymoquinone-Induced Reactivation of Tumor Suppressor Genes in Cancer Cells Involves Epigenetic Mechanisms
Shahad A Qadi, Mohammed Hassan, Ryan A. Sheikh, et al.
Epigenetics Insights (2019) Vol. 12
Open Access | Times Cited: 32
CXCL8 Promotes Endothelial-to-Mesenchymal Transition of Endothelial Cells and Protects Cells from Erastin-Induced Ferroptosis via CXCR2-Mediated Activation of the NF-κB Signaling Pathway
Haizhou Ji, Li Chen, Mi Ren, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1210-1210
Open Access | Times Cited: 10
Chromatin Remodeling in Cervical Tumor Cells Regulates Proangiogenic Genes
Sharath Mohan Bhat, Nischal L. Simha, Shailaja Hegde, et al.
(2025), pp. 69-88
Closed Access
Targeting epigenetic modifiers to reprogramme macrophages in non-resolving inflammation-driven atherosclerosis
Fengyan Jin, Jian Li, Jianfeng Guo, et al.
European Heart Journal Open (2021) Vol. 1, Iss. 2
Open Access | Times Cited: 22
Discovery of potent pyrrolo-pyrimidine and purine HDAC inhibitors for the treatment of advanced prostate cancer
Davide Moi, Davide Bonanni, Silvia Belluti, et al.
European Journal of Medicinal Chemistry (2023) Vol. 260, pp. 115730-115730
Open Access | Times Cited: 9
Endometriosis Malignant Transformation: Epigenetics as a Probable Mechanism in Ovarian Tumorigenesis
Jiaxing He, Weiqin Chang, Chunyang Feng, et al.
International Journal of Genomics (2018) Vol. 2018, pp. 1-13
Open Access | Times Cited: 24
Research Advances in the Use of Histone Deacetylase Inhibitors for Epigenetic Targeting of Cancer
Yu Bai, Daid Ahmad, Ting Wang, et al.
Current Topics in Medicinal Chemistry (2019) Vol. 19, Iss. 12, pp. 995-1004
Closed Access | Times Cited: 20
IFNγ-Induced Bcl3, PD-L1 and IL-8 Signaling in Ovarian Cancer: Mechanisms and Clinical Significance
Suprataptha U. Reddy, Fatema Zohra Sadia, Aleš Vančura, et al.
Cancers (2024) Vol. 16, Iss. 15, pp. 2676-2676
Open Access | Times Cited: 2
Epigenetic regulation of interleukin-8 expression by class I HDAC and CBP in ovarian cancer cells
Himavanth R. Gatla, Yue Zou, Mohammad M. Uddin, et al.
Oncotarget (2017) Vol. 8, Iss. 41, pp. 70798-70810
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top